The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030
Bispecific antibodytherapeutics represent a transformative approach to modern treatment; over theyears, this upcoming class of ‘two-target’ artificially engineered drugs havegenerated significant enthusiasm within the medical science community
Roots Analysis is pleased toannounce the publication of its recent study, titled, “Bispecific AntibodyTherapeutics Market (4th Edition), 2020-2030.”
The report features an extensive study of the currentmarket landscape, offering an informed opinion on the likely adoption of thesetherapeutics over the next decade. The study features an in-depth analysis, highlightingthe capabilities of various stakeholders engaged in this domain. Amongst otherelements, the report includes:
§ A detailed assessmentof the current market landscape of drug developers engaged in the developmentof bispecific antibody therapeutics.
§ A comprehensive analysisof novel technology platforms that are either currently available or beingdeveloped for the generation of bispecific antibody therapeutics.
§ Detailed profiles of marketedand clinical stage (phase II and phase III) bispecific antibody therapeutics.
§ Key takeaways fromthe bispecific antibody therapeutics pipeline.
§ An analysis of theinitiatives of big biopharma players engaged in this domain.
§ An analysis of recentpartnerships and collaboration agreements inked in bispecific antibodytherapeutics domain.
§ A review on the keysteps involved and challenges associated with the manufacturing of bispecificantibodies.
§ A clinical trialanalysis of ongoing and planned studies related to bispecific antibody therapeutics.
§ A review of the keypromotional strategies that have been adopted by the developers of the marketedbispecific antibodies.
§ A discussion onimportant, industry-specific trends, key market drivers and challenges, under aSWOT framework.
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
- Target Disease Indication
§ Autoimmune Disorders
§ Eye Disorders
§ Genetic Disorders
§ HematologicalMalignancies
§ Infectious Diseases
§ InflammatoryDisorders
§ Skin Disorders
- Mechanism of Action
§ Cytokines Retargeting/ Neutralization
§ Dual Ligands Blocking
§ T-cell Retargeting /Activation
§ Others
- Target Antigens
§ CD3 x CD19
§ CD30 x CD16A
§ Factor IXa x Factor X
§ IL-1α x IL-1β
§ IL-13 x IL-4
§ IL-17A x Albumin
§ IL-17A x IL-17F
§ Psl x PcrV
§ TNF-α x HAS
§ VEGF-A x ANG2
§ Others
- Antibody Format
§ Asymmetric
§ Fragments
§ Symmetric
§ Others
- Key Geographical Region
§ North America
§ Europe
§ Asia-Pacific
Transcriptsof interviews held with the following senior level representatives ofstakeholder companies:
§ Martin Steiner (ChiefExecutive Officer, Synimmune)
§ Ludger Große-Hovest(Chief Scientific Officer, Synimmune)
§ Jane Dancer (ChiefBusiness Officer, F-Star)
§ Siobhan Pomeroy(Senior Director, Business Development, Cytom X)
§ Yinjue Wang(Associate Director, Process Development, Innovent Biologics)
Keycompanies covered in the report
§ Amgen
§ Ablynx
§ AbbVie
§ Affibody
§ Affimed
§ Alphamab
§ AstraZeneca
§ Avillion
§ ChugaiPharmaceuticals
§ Eddingpharm
§ GSK
§ Merck
§ Merus
§ Roche
§ RegeneronPharmaceuticals
§ TaishoPharmaceuticals
§ Zymeworks
Formore information please click on the following https://www.rootsanalysis.com/reports/286/request-sample.html:
https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
Other RecentOfferings
1. Global PreventiveVaccines Market, 2020-2030
2. Endocannabinoid SystemTargeted Therapeutics Market, 2019-2030
3. Antibody ContractManufacturing Market, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
